127 related articles for article (PubMed ID: 38890728)
1. Sensitivity analysis for principal ignorability violation in estimating complier and noncomplier average causal effects.
Nguyen TQ; Stuart EA; Scharfstein DO; Ogburn EL
Stat Med; 2024 Jun; ():. PubMed ID: 38890728
[TBL] [Abstract][Full Text] [Related]
2. Identification of complier and noncomplier average causal effects in the presence of latent missing-at-random (LMAR) outcomes: a unifying view and choices of assumptions.
Nguyen TQ; Carlson MC; Stuart EA
Biostatistics; 2024 Apr; ():. PubMed ID: 38579199
[TBL] [Abstract][Full Text] [Related]
3. Profiling compliers and noncompliers for instrumental variable analysis with covariates: A weighting approach.
Choi BY
PLoS One; 2023; 18(6):e0283223. PubMed ID: 37319247
[TBL] [Abstract][Full Text] [Related]
4. Performance of principal scores to estimate the marginal compliers causal effect of an intervention.
Porcher R; Leyrat C; Baron G; Giraudeau B; Boutron I
Stat Med; 2016 Feb; 35(5):752-67. PubMed ID: 26381261
[TBL] [Abstract][Full Text] [Related]
5. On the use of propensity scores in principal causal effect estimation.
Jo B; Stuart EA
Stat Med; 2009 Oct; 28(23):2857-75. PubMed ID: 19610131
[TBL] [Abstract][Full Text] [Related]
6. Multiply robust estimation of principal causal effects with noncompliance and survival outcomes.
Cheng C; Guo Y; Liu B; Wruck L; Li F; Li F
Clin Trials; 2024 May; ():17407745241251773. PubMed ID: 38813813
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity analyses for the principal ignorability assumption using multiple imputation.
Wang C; Zhang Y; Mealli F; Bornkamp B
Pharm Stat; 2023 Jan; 22(1):64-78. PubMed ID: 36053974
[TBL] [Abstract][Full Text] [Related]
8. Nonparametric inference of complier quantile treatment effects in randomized trials with imperfect compliance.
Mao L
Biostat Epidemiol; 2022; 6(2):249-265. PubMed ID: 37551295
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
Wang Y; Berlin JA; Pinheiro J; Wilcox MA
Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
[TBL] [Abstract][Full Text] [Related]
11. Clarifying selection bias in cluster randomized trials.
Li F; Tian Z; Bobb J; Papadogeorgou G; Li F
Clin Trials; 2022 Feb; 19(1):33-41. PubMed ID: 34894795
[TBL] [Abstract][Full Text] [Related]
12. Patient Centered Hazard Ratio Estimation Using Principal Stratification Weights: Application to the NORCCAP Randomized Trial of Colorectal Cancer Screening.
MacKenzie TA; Løberg M; O'Malley AJ
Obs Stud; 2016 Mar; 2():29-50. PubMed ID: 29644344
[TBL] [Abstract][Full Text] [Related]
13. Estimation and inference for the causal effect of receiving treatment on a multinomial outcome.
Cheng J
Biometrics; 2009 Mar; 65(1):96-103. PubMed ID: 18373714
[TBL] [Abstract][Full Text] [Related]
14. Assessing the sensitivity of methods for estimating principal causal effects.
Stuart EA; Jo B
Stat Methods Med Res; 2015 Dec; 24(6):657-74. PubMed ID: 21971481
[TBL] [Abstract][Full Text] [Related]
15. Nonparametric Bounds and Sensitivity Analysis of Treatment Effects.
Richardson A; Hudgens MG; Gilbert PB; Fine JP
Stat Sci; 2014 Nov; 29(4):596-618. PubMed ID: 25663743
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity Analysis and Bounding of Causal Effects With Alternative Identifying Assumptions.
Jo B; Vinokur AD
J Educ Behav Stat; 2011 Aug; 36(1):415-440. PubMed ID: 21822369
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity analysis for unmeasured confounding in principal stratification settings with binary variables.
Schwartz S; Li F; Reiter JP
Stat Med; 2012 May; 31(10):949-62. PubMed ID: 22362635
[TBL] [Abstract][Full Text] [Related]
18. Estimating the causal effect of milk powder supplementation on bone mineral density: a randomized controlled trial with both non-compliance and loss to follow-up.
Chen Y; Zhang Q; Wang Y; Xiao Y; Fu R; Bao H; Liu M
Eur J Clin Nutr; 2015 Jul; 69(7):824-30. PubMed ID: 25626413
[TBL] [Abstract][Full Text] [Related]
19. A comparison of methods to estimate the survivor average causal effect in the presence of missing data: a simulation study.
McGuinness MB; Kasza J; Karahalios A; Guymer RH; Finger RP; Simpson JA
BMC Med Res Methodol; 2019 Dec; 19(1):223. PubMed ID: 31795945
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of estimands in clinical trials with imperfect compliance.
Chen H; Heitjan DF
Int J Biostat; 2024 May; 20(1):57-67. PubMed ID: 37365674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
